A B S T R A C T An isolated deficiency of pituitary gonadotropins was demonstrated in six 46 XY males, 22 to 36 years of age, with and without anosmia. Undetectable or low levels of serum follicle-stimulating hormone (FSH) and luteinizing hormone (LH) clearly separated hypogonadotropic from normal adult males. Chronic (8-12 wk) administration of clomiphene citrate caused no increase in serum FSH or LH in gonadotropin-deficient subjects. However, the administration of synthetic luteinizing hormone releasing factor (LRF) resulted in the appearance of serum LH and, to a lesser degree, serum FSH in three subjects tested. While levels of plasma testosterone were significantly lower in gonadotropin-deficient subjects, plasma androstenedione and dehydroepiandrosterone were in a range similar to that of age-matched normal men. Treatment with human chorionic gonadotropin (HCG) increased levels of plasma testosterone to normal adult male values in all gonadotropin-deficient subjects. Cessation of treatment with HCG resulted in the return of plasma testosterone to low, pretreatment levels. That HCG therapy with resultant normal levels of plasma testosterone may somehow stimulate endogenous gonadotropin secretion in gonadotropin-deficient subjects was not evident. The adult male levels of serum FSH and LH after LRF, and plasma testosterone after HCG, confirm pituitary and Leydig cell responsiveness in these subjects.
INTRODUCTION
An isolated deficiency of gonadotropin secretion has been noted for many years (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . Despite this knowledge, few studies are available which have examined blood levels of androgens and gonadotropins before and after treatment with clomiphene citrate and human Received for publication 14 July 1973 and in revised form 8 October 1973. chorionic gonadotropin (HCG)1 (17) . We have studied six males with hypogonadism due to an isolated deficiency of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) and have quantitated levels of pituitary gonadotropins, testosterone,2 androstenedione, and dehydroepiandrosterone before and during treatment with clomiphene citrate and HCG. Additionally, we have achieved normal levels of serum FSH and LH with the administration of luteinizing hormone releasing factor (LRF). These results point to a deficiency of hypothalamic releasing factor as an explanation of the isolated deficiency of gonadotropins found in these subjects.
METHODS
Urinary 17-ketosteroids were measured by the procedure of Vestergaard (18) . Plasma cortisol and 1 1-deoxycortisol were measured by double-isotope derivative techniques (19) . Plasma testosterone, dehydroepiandrosterone, and androstenedione were measured by a modification of the doubleisotope derivative technique combined with gas-liquid chromatography, as described by Kliman and Briefer (20) . Preliminary separation of testosterone, dehydroepiandrosterone, and androstenedione was accomplished in the paper chromatographic system: hexane 100:methanol 90: water 10 
Tests
Hypothalamic-pituitary responsiveness. Insulin, 0.1 U/ kg, was given intravenously and blood was obtained at 0, 30, 60, 90, and 120 min. In this laboratory plasma growth hormone in normal men increased to at least 10 ng/ml when the blood sugar decreased by 50% of the initial concentration.
Metyrapone (SU-4885), 750 mg, was given orally every 4 h for six doses. A normal response is defined as a fall in plasma cortisol (50% or greater) accompanied by a rise in plasma 11-deoxycortisol concentration to 10 ,ug/100 ml or more (19) . Plasma 1l-deoxycortisol was not measured before SU-4885 since its concentration is negligible (<0.5 ,ug/100 ml).
Clomiphene citrate, 200 mg, was given orally for 7 days, and blood was obtained at 8 A.M. on days 6 and 7. A normal response in this laboratory in normal men, ages 20-40 years, is an increase of at least 100%o in serum levels of FSH and LH, respectively. Additionally, clomiphene citrate, 25-200 mg daily, was given for 8-12 wk, and serial measurements of serum FSH, LH, and plasma testosterone were determined.
Highly purified, synthetic LRF supplied by Dr. R. Guillemin, La Jolla, Calif., and synthesized by Dr. J. Rivier (24) was utilized in the present study. It has full biological activity in the various in vitro and in vivo assay systems used to characterize LRF (25) . Millipore-filtered, pyrogenfree LRF, diluted in 0.5 g/100 ml human serum albumin in distilled water, was stored at 4°C until used. At the time of this study, 1.0-ml (100 ,ug/ml) quantities were rapidly injected intravenously. Blood was withdrawn from a peripheral venous catheter before administration of LRF (time 0) and 5, 10, 15, 30, 45, 60, 90, 120, 240, and 480 min later. Samples were analyzed for FSH and LH.
Leydig cell responsiveness. HCG (APL, Ayerst Laboratories, New York), 5,000 U intramuscularly, was given daily for 4 days, then three times per week. Levels of plasma androstenedione, dehydroepiandrosterone, testosterone, and serum LH (HCG) were measured before, during, and after HCG administration. All gonadotropin-deficient subjects had undetectable (<1 mIU/ml) or low (<2 mIU/ml) levels of LH before therapy. During HCG administration, serum levels of HCG, and not LH, were measured because of cross-reactivity of the antibody. but no treatment 3 mo before the beginning of the study. J. S. and T. B. received no hormonal therapy before the initiation of this study. All subjects showed retarded sexual development and/or eunuchoid habitus. Testicular size (greatest diameter) was less than 2 cm in all subjects except T. B. (3.0 cm). One subject, L. E., was anosmic and had a congenital absence of the left kidney. Cryptorchidism, midline defects (harelip or cleft palate), skeletal anomalies (short fourth metacarpal), nerve deafness, and colorblindness were absent in all subjects. Two subjects, J. J. and D. J., were brothers, and from a total of four other adult male siblings, only two had achieved puberty and proved fertile. Three sisters had reached menarche, and one was fertile. The other hypogonadal subjects had no siblings and gave no family history of hypogonadism. X-ray examination of the skull, visual field examination, and buccal smear for sex chromatin were negative in all subjects. pin-deficient males (mean 0.03±0.03 g/i100 ml) were significantly less than age-matched normal males (mean 0.62±0.29 Ag/100 ml) (P < 0.01) (Fig. 3) . After 4 days of HCG administration (mean 0.14±0.09 g/i100 ml) plasma testosterone increased compared to pretreatment levels (P < 0.05). After 2 wk (mean 0.45±0.37 ug/100 ml) and 4 wk (mean 0.60±)0.37 ug/lOO ml) concentrations increased significantly (P < 0.01) and were similar to adult male values (Fig. 3) . D. J., the single gonadotropin-deficient subject whose plasma testosterone (0.08 iAg/iOO ml) was above the female range (< 0.06 tg/100 ml) was the only gonadotropin-deficient subject whose serum LH (1.7 mIU/ml) was detectable. That normal concentrations of plasma testosterone were achieved in all gonadotropin-deficient subjects with HCG administration clearly indicated the presence of Leydig cell responsiveness. Thus, it seemed pertinent to show whether onset of gonadotropin secretion would occur after (a) withdrawal of HCG treatment, (b) chronic treatment with clomiphene citrate, and (c) administration of LRF.
RESULTS
Concentrations of serum LH (HCG) and plasma testosterone were measured during a 12-wk period of HCG administration (Fig. 4) . During the period of treatment, serum LH (HCG) levels ranged between 50 and 175 mIU/ml. Plasma testosterone was in the normal adult male range in all subjects during HCG administration. 6 ness in affected individuals becomes paramount since separate normal from low levels (17, (27) (28) (29) (30) . This may the success of newer modes of therapy in this disorder be related to methodology, since both precision and sensiwill depend on such responsiveness. tivity are less dependable when concentrations of gonadoIn the present study of gonadotropin-deficient sub-tropins are near the limits of detection by radioimmunojects, two were brothers, while the other four subjects assay (31) . A previous study separated gonadotropinrepresented isolated, sporadic occurrences. In addition deficient from normal adult males by measuring immunoto the findings of hypogonadism in all subjects, only reactive FSH and LH in urine extracts (17) . In the L. E. displayed other anomalies, specifically anosmia and present study, radioimmunoassay of a single blood sample unilateral renal agenesis, an association previously re-for both FSH and LH permitted us to clearly separate viewed by Nowakowski and Lenz (7) .
hypogonadal males with deficient gonadotropin secretion Although the advent of radioimmunoassay of pituitary from normal adult males. No increase in serum FSH or gonadotropins provided a means to quantify FSH and LH was observed after the 7-day course of clomiphene LH in blood and easily distinguish between elevated and administration in all gonadotropin-deficient subjects normal levels, it remained inadequate to quantitatively studied; these observations are in agreement with earlier (32) . Moreover, similar treatment with HCG in some prepubertal males increased levels of plasma testosterone into the range of normal men (33, 34) . However, chronic HCG treatment in four out of six hyposmic patients reported by Bardin et al. (17) failed to elicit either a normal adult level of plasma testosterone or clinical evidence of masculinization. This observation led them to conclude that these patients manifested Leydig cell insensitivity to gonadotropin administration as well as impaired gonadotropin secretion. In contrast, all gonadotropin-deficient subjects in this study attained normal adult levels of plasma testosterone within 4 wk of HCG administration, 5,000 U, three times per week, providing clear evidence of Leydig cell responsiveness.
In occasional patients with hypogonadotropic hypogonadism, gonadotropin therapy appears to stimulate endogenous gonadotropin production making further exogenous treatment unnecessary (35) . Unfortunately, this event was not observed in any subject in the present study with or without anosmia, since cessation of treatment with HCG resulted in the return of plasma testosterone to low, prepubertal levels, while serum LH was undetectable.
The effectiveness of clomiphene in initiating gonadotropin secretion in anosmic subjects with isolated deficiency of FSH and LH has been debated (36) (37) (38) . Recently, Santen, Leonard, Sherins, Gandy, and Paulsen observed no significant increments in serum FSH and LH in gonadotropin-deficient males with or without anosmia following 3-4 wk of clomiphene administration (39 However, the dramatic release of LH and FSH in three of these subjects following administration of LRF clearly localizes the defect to the hypothalamus and confirms the presence of LH and FSH in the pituitary. Two additional reports (41) (42) have also demonstrated pituitary responsiveness of LRF administration. Although normal adult levels of serum FSH and LH were achieved, these concentrations were never as great as those in normal subjects despite 3 days of LRF administration. Perhaps pituitary responsiveness, like testicular responsiveness, requires more prolonged stimulation with its respective tropic hormone to achieve normal adult function.
The observations in these studies are particularly meaningful since Leydig cell and pituitary responsiveness must be present before therapeutic modalities such as treatment with combined preparations of HCG and HMG' or gonadotropin releasing factors can be successful in achieving testicular maturation.
